A. Gaspardone et al., SUBSTANCE-P POTENTIATES THE ALGOGENIC EFFECTS OF INTRAARTERIAL INFUSION OF ADENOSINE, Journal of the American College of Cardiology, 24(2), 1994, pp. 477-482
Objectives. This study investigated whether substance P potentiates th
e muscular and cardiac pain caused by the intraarterial infusion of ad
enosine, an autocoid known to induce muscular and cardiac ischemic-lik
e pain in humans. Background. Substance P is involved in the generatio
n of neurogenic inflammation and causes cutaneous hyperalgesia. Be cau
se substance P is present in perivascular nerves it might also cause m
uscular and cardiac hyperalgesia. To test this hypothesis its effects
on adenosine induced muscular and cardiac pain were investigated in hu
mans. Methods. A randomized, crossover study of the algogenic effects
of the intrailiac infusion of increasing scalar doses (from 125 to 2,0
00 mu g/min) of adenosine or substance P (11.2 pmol/min) for 3 min, fo
llowed by the simultaneous infusion of substance P plus the same doses
of adenosine, was carried out in nine patients with no evidence of pe
ripheral vascular disease. A similar protocol was carried out by infus
ing increasing scalar doses of adenosine (from 50 to 800 mu g/min) or
substance P (11.2 pmol/min) far 3 min, followed by the simultaneous in
fusion of substance P plus the same doses of adenosine, into the left
coronary artery of eight patients with angina. Pain severity, assessed
by a visual analog scale, is presented as median. The remaining data
are presented as mean value +/- 1 SD. Results. All patients experience
d pain during both adenosine and substance P plus adenosine infusion;
no patient experienced pain during the infusion of substance P alone.
During intrailiac infusion, all patients experienced pain in the right
leg that occurred earlier (207 +/- 152 vs. 321 +/- 154 s, p < 0.05) a
nd was greater (47 vs. 30 mm, p < 0.05) during the simultaneous infusi
on of substance P plus adenosine than during the infusion of adenosine
. Similarly, during intracoronary infusion, all patients experienced c
hest pain that occurred earlier (409 +/- 242 vs. 596 +/- 210 s, p < 0.
05) and was greater (51 vs. 33 mm, p < 0.05) during the simultaneous i
nfusion of substance P plus adenosine than during infusion of adenosin
e. No patient exhibited electrocardiographic signs of ischemia. Conclu
sions. Substance P does not cause muscular or cardiac pain, but it pro
vokes muscular and cardiac hyperalgesia.